XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 11,009 $ 100,808
Short-term investments 183,909 56,458
OMIDRIA contract royalty asset, short-term 28,797 44,319
Receivables, net 213,221 38,155
Prepaid expense and other assets 6,300 8,216
Total current assets 443,236 247,956
OMIDRIA contract royalty asset 123,425 140,251
Right of use assets 21,762 28,276
Property and equipment, net 1,492 1,731
Restricted investments 1,054 1,054
Total assets 590,969 419,268
Current liabilities:    
Accounts payable 5,989 13,400
Accrued expenses 30,551 33,134
Current portion of unsecured convertible senior notes, net 94,381  
Current portion of OMIDRIA royalty obligation 1,152  
Current portion of lease liabilities 4,310 5,255
Total current liabilities 136,383 51,789
Unsecured convertible senior notes, net 220,906 313,458
OMIDRIA royalty obligation 125,126  
Lease liabilities, non-current 22,426 29,126
Other accrued liabilities - noncurrent 444 1,115
Commitments and contingencies (Note 11)
Shareholders' equity:    
Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at December 31, 2022 and December 31, 2021.
Common stock, par value $0.01 per share, 150,000,000 shares authorized at December 31, 2022 and December 31, 2021; 62,828,765 and 62,628,855 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively. 628 626
Additional paid-in capital 720,773 706,288
Accumulated deficit (635,717) (683,134)
Total shareholders' equity 85,684 23,780
Total liabilities and shareholders' equity $ 590,969 $ 419,268